Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Host Defense is the leading U.S. mushroom supplement brand, founded by mycologist Paul Stamets, specializing in mushroom mycelium-based products for immune and cognitive health. Products are certified organic, non-GMO, vegan, gluten-free, and third-party tested for purity and strength. The company emphasizes scientifically validated formulations, sustainability, and environmental responsibility, but does not develop FDA-regulated pharmaceuticals or biologics; its products are dietary supplements, not drugs. [1][3][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Host Defense.